SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
22.81
-0.84 (-3.57%)
At close: Apr 28, 2026, 4:00 PM EDT
23.00
+0.20 (0.86%)
After-hours: Apr 28, 2026, 4:00 PM EDT
SpyGlass Pharma Market Cap
SpyGlass Pharma has a market cap or net worth of $762.29 million as of April 28, 2026.
Market Cap
762.29M
Enterprise Value
654.43M
1-Year Change
n/a
Ranking
Category
Stock Price
$22.81
Market Cap Chart
Since the IPO on February 6, 2026, SpyGlass Pharma's market cap has increased from $510.58M to $762.29M, an increase of 49.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 790.54M | 54.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arbutus Biopharma | 827.15M |
| Crescent Biopharma | 823.70M |
| ARS Pharmaceuticals | 823.17M |
| Kura Oncology | 821.94M |
| SELLAS Life Sciences Group | 800.94M |
| Cullinan Therapeutics | 800.16M |
| Allogene Therapeutics | 794.59M |
| Solid Biosciences | 779.29M |